Danaparoid: Clinical Use Recommendations
Author Information
Author(s): Bauersachs Rupert M., Lindhoff-Last Edelgard, Klamroth Robert, Koster Andreas, Schindewolf Marc, Magnani Harry
Primary Institution: Cardioangiology Center Bethanien, Frankfurt, Germany
Hypothesis
What are the optimal dosing regimens for danaparoid in various clinical situations?
Conclusion
The study provides detailed interdisciplinary dosing recommendations for the safe and effective use of danaparoid.
Supporting Evidence
- Danaparoid has been used for over 40 years for DVT prophylaxis and treatment of HIT.
- Current dosing recommendations are based on more than 40 years of clinical experience.
- Interdisciplinary expert groups analyzed evidence to develop consensus on dosing regimens.
Takeaway
Danaparoid is a medicine used to prevent blood clots, and this study gives doctors advice on how to use it safely in different situations.
Methodology
The study summarizes evidence from clinical studies, case reports, and expert consensus to develop dosing recommendations.
Potential Biases
Potential biases may arise from the reliance on published studies and expert consensus.
Limitations
The recommendations are based on existing literature and expert opinion, which may not cover all clinical scenarios.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website